
    
      This is a multicentric randomized comparison between iso-osmolar and ipo-osmolar contrast
      agents in patients treated with primary PCI with the evaluation of contrast-induced
      nephropathy incidence and myocardial tissue reperfusion. The study was designed as a
      non-inferiority trial.
    
  